- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01625676
Study of Modified Constraint-Induced Aphasia Therapy Schedule to Treat Patients Following Sub-acute Stroke (MCIAT)
June 19, 2012 updated by: NRZ Magdeburg Median Kliniken GmbH & Co
Constraint-Induced Aphasia Therapy Following Sub-acute Stroke: A Modified Therapy Schedule
The purpose of this study is to assess the feasibility of modified Constraint-Induced Aphasia Therapy (CIAT) in the early sub-acute stage and to examine the efficacy of modified CIAT versus standard treatment with the same intensity of intervention.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Magdeburg, Germany, 39120
- NRZ Median Klinik
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
34 years to 84 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- clinical diagnosis of first-ever stroke
- aphasia in sub-acute stage
- german speakers
Exclusion Criteria:
- presence of residual aphasia
- dysarthria and apraxia of speech
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CIAT-Group
Patients received a modified constraint-induced therapy schedule
|
2 hours of training over 15 days
|
Active Comparator: standard treatment group
patients received a standard aphasia therapy
|
2 hours of training over 15 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change of aphasia and aphasic syndromes by Aachen Aphasia Test (AAT)
Time Frame: pretreatment and 4 weeks
|
pretreatment and 4 weeks
|
change from pretreatment in Aachen Aphasia Test at 8 weeks
Time Frame: pretreatment and 8 weeks
|
pretreatment and 8 weeks
|
change from pretreatment in Aachen Aphasia Test at 1 year
Time Frame: pretreatment and 1 year
|
pretreatment and 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change of Communicative Activity (CAL)
Time Frame: pretreatment and 4 weeks
|
pretreatment and 4 weeks
|
change from pretreatment in communication activity (CAL)at 8 weeks
Time Frame: pretreatment and 8 weeks
|
pretreatment and 8 weeks
|
Change from pretreatment in communication activity (CAL)at 1 year
Time Frame: pretreatment and 1 year
|
pretreatment and 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Almut A Sickert, PhD, NRZ Median Klinik Magdeburg
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2004
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
June 15, 2012
First Submitted That Met QC Criteria
June 19, 2012
First Posted (Estimate)
June 21, 2012
Study Record Updates
Last Update Posted (Estimate)
June 21, 2012
Last Update Submitted That Met QC Criteria
June 19, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SIC-2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aphasia
-
University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Aphasia | Stroke, Ischemic | Aphasia, Broca | Aphasia, Anomic | Aphasia, Global | Aphasia, Fluent | Aphasia, Mixed | Aphasia, Jargon | Aphasia, Expressive | Aphasia, ConductionUnited States
-
University of Texas at AustinUniversity of California, San Francisco; National Institute on Deafness and...Active, not recruitingPrimary Progressive Aphasia | Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Semantic Memory Disorder | Nonfluent Aphasia, Progressive | Aphasia, ProgressiveUnited States
-
Institute for Bioengineering of CataloniaHospital Universitari Joan XXIII de Tarragona.; Universitat Pompeu FabraCompletedAphasia | Aphasia, Broca | Aphasia, Wernicke | Aphasia, Fluent | Aphasia, NonfluentSpain
-
Flint Rehabilitation Devices, LLCUniversity of TexasCompleted
-
Mayo ClinicNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingPrimary Progressive Aphasia | Apraxia of Speech | PPA | Non-fluent Aphasia | Primary Progressive Non-fluent AphasiaUnited States
-
University of California, BerkeleyUniversity of California, San Francisco; California State University, East Bay and other collaboratorsRecruitingAphasia | Aphasia, Acquired | Aphasia Non Fluent | Aphasia, FluentUnited States
-
Mayo ClinicCompletedPrimary Progressive Aphasia | Aphasia | Semantic Dementia | Apraxia of Speech | Primary Progressive Nonfluent Aphasia | PPA | Non-fluent Aphasia | Progressive AphasiaUnited States
-
Montreal Heart InstituteActive, not recruitingNeurodegenerative Diseases | Primary Progressive Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Non-fluent AphasiaCanada
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RecruitingPrimary Progressive Aphasia | Logopenic Progressive Aphasia | Non-Fluent Primary Progressive AphasiaUnited States, Canada
-
University of British ColumbiaTerminatedPrimary Progressive Nonfluent AphasiaCanada
Clinical Trials on Investigate efficacy of modified ciat schedule
-
National Institute on Drug Abuse (NIDA)CompletedHIV Infection | Hepatitis B Infection | Hepatitis C InfectionUnited States
-
Wenzhou Medical UniversityCompleted
-
Jilin UniversityUnknownAntineoplastic Combined Chemotherapy ProtocolsChina